Middle East Healthcare Company (4009.SR) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Middle East Healthcare Company, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 9.93x | 22.42x | 45.11x | 31.52x | 248.29x | 39.35x |
| P/B Ratio | 1.60x | 3.89x | 5.35x | 1.74x | 2.32x | 2.03x |
| P/S Ratio | 0.97x | 2.19x | 3.06x | 1.10x | 1.56x | 1.82x |
| Profitability | ||||||
| Gross Margin | 37.4% | 38.6% | 37.8% | 31.6% | 32.5% | 33.9% |
| Operating Margin | 12.6% | 15.3% | 12.9% | 6.5% | 2.9% | 7.1% |
| Net Margin | 9.7% | 9.8% | 6.8% | 3.5% | 0.6% | 4.6% |
| EBITDA Margin | 20.5% | 25.9% | 20.1% | 13.3% | 10.4% | 13.8% |
| Liquidity | ||||||
| Current Ratio | 1.55x | 1.72x | 1.29x | 1.20x | 1.15x | 1.56x |
| Quick Ratio | 1.48x | 1.67x | 1.25x | 1.11x | 1.04x | 1.43x |
| Leverage | ||||||
| Debt/Equity | 1.36x | 1.52x | 1.64x | 1.64x | 1.56x | 0.97x |
YoY = year-over-year change. Source: FMP..